Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer: A Systematic Review and Meta-analysis
- Clin. Nucl. Med., Jan 19 2024, | https://doi.org/10.1097/RLU.0000000000005022